MorphoSys Analyst Ratings
MorphoSys Analyst Ratings
| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 11/21/2023 | 274.45% | JMP Securities | → $17 | Reiterates | Market Outperform → Market Outperform |
| 10/13/2023 | 102.64% | Morgan Stanley | $3.7 → $9.2 | Upgrades | Underweight → Overweight |
| 09/15/2023 | 103.74% | Goldman Sachs | $3.5 → $9.25 | Upgrades | Sell → Neutral |
| 06/22/2023 | 230.4% | JMP Securities | → $15 | Reiterates | Market Outperform → Market Outperform |
| 06/16/2023 | 274.45% | Wells Fargo | → $17 | Initiates Coverage On | → Overweight |
| 06/16/2023 | 120.26% | JP Morgan | $3.3 → $10 | Upgrades | Underweight → Overweight |
| 01/03/2023 | — | JP Morgan | Downgrades | Neutral → Underweight | |
| 11/18/2022 | 230.4% | JMP Securities | $32 → $15 | Maintains | Market Outperform |
| 01/14/2022 | — | Morgan Stanley | Downgrades | Overweight → Equal-Weight | |
| 08/06/2021 | — | Deutsche Bank | Downgrades | Buy → Hold | |
| 06/11/2021 | 428.63% | JP Morgan | $32 → $24 | Downgrades | Overweight → Neutral |
| 06/03/2021 | — | Bryan Garnier | Downgrades | Buy → Neutral | |
| 06/03/2021 | — | SVB Leerink | Upgrades | Market Perform → Outperform | |
| 05/24/2021 | 516.74% | Morgan Stanley | → $28 | Upgrades | Equal-Weight → Overweight |
| 03/23/2021 | — | SVB Leerink | Downgrades | Outperform → Market Perform | |
| 11/25/2020 | — | Morgan Stanley | Initiates Coverage On | → Equal-Weight | |
| 11/20/2019 | — | Guggenheim | Initiates Coverage On | → Buy |
| 日期 | 上行/下行 | 分析公司 | 目標價格變動 | 評級變動 | 之前/當前的評級 |
|---|---|---|---|---|---|
| 11/21/2023 | 274.45% | JMP 證券 | → 17 美元 | 重申 | 市場跑贏大盤 → 市場跑贏大盤 |
| 10/13/2023 | 102.64% | 摩根士丹利 | 3.7 美元 → 9.2 美元 | 升級 | 體重過輕 → 超重 |
| 09/15/2023 | 103.74% | 高盛 | 3.5 美元 → 9.25 美元 | 升級 | 賣出 → 中立 |
| 06/22/2023 | 230.4% | JMP 證券 | → 15 美元 | 重申 | 市場跑贏大盤 → 市場跑贏大盤 |
| 06/16/2023 | 274.45% | 富國銀行 | → 17 美元 | 啓動覆蓋範圍開啓 | → 超重 |
| 06/16/2023 | 120.26% | 摩根大通 | 3.3 美元 → 10 美元 | 升級 | 體重過輕 → 超重 |
| 01/03/2023 | — | 摩根大通 | 降級 | 中性 → 體重不足 | |
| 11/18/2022 | 230.4% | JMP 證券 | 32 美元 → 15 美元 | 維護 | 市場表現跑贏大盤 |
| 2022 年 1 月 14 日 | — | 摩根士丹利 | 降級 | 超重 → 重量相等 | |
| 2021 年 6 月 8 日 | — | 德意志銀行 | 降級 | 買入 → 持有 | |
| 06/11/2021 | 428.63% | 摩根大通 | 32 美元 → 24 美元 | 降級 | 超重 → 中性 |
| 06/03/2021 | — | 布萊恩·卡尼爾 | 降級 | 買入 → 中性 | |
| 06/03/2021 | — | SVB Leerink | 升級 | 市場表現 → 跑贏大盤 | |
| 05/24/2021 | 516.74% | 摩根士丹利 | → 28 美元 | 升級 | 重量相等 → 超重 |
| 03/23/2021 | — | SVB Leerink | 降級 | 跑贏大盤 → 市場表現 | |
| 11/25/2020 | — | 摩根士丹利 | 啓動覆蓋範圍開啓 | → 重量相等 | |
| 2019 年 11 月 20 日 | — | 古根海姆 | 啓動覆蓋範圍開啓 | → 購買 |
What is the target price for MorphoSys (MOR)?
MorphoSys (MOR) 的目標價格是多少？
The latest price target for MorphoSys (NASDAQ: MOR) was reported by JMP Securities on November 21, 2023. The analyst firm set a price target for $17.00 expecting MOR to rise to within 12 months (a possible 274.45% upside). 7 analyst firms have reported ratings in the last year.
摩根大通證券於2023年11月21日公佈了MorphoSys（納斯達克股票代碼：MOR）的最新目標股價。該分析公司將目標股價定爲17.00美元，預計MOR將在12個月內升至12個月內（可能上漲274.45％）。去年有7家分析公司公佈了評級。
What is the most recent analyst rating for MorphoSys (MOR)?
MorphoSys (MOR) 的最新分析師評級是多少？
The latest analyst rating for MorphoSys (NASDAQ: MOR) was provided by JMP Securities, and MorphoSys reiterated their market outperform rating.
MorphoSys（納斯達克股票代碼：MOR）的最新分析師評級由JMP Securities提供，MorphoSys重申了其市場跑贏大盤的評級。
When is the next analyst rating going to be posted or updated for MorphoSys (MOR)?
MorphoSys（MOR）的下一份分析師評級何時發佈或更新？
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of MorphoSys, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for MorphoSys was filed on November 21, 2023 so you should expect the next rating to be made available sometime around November 21, 2024.
分析師在進行了廣泛的研究後得出了股票評級，其中包括瀏覽公開財務報表，與MorphoSys的高管和客戶交談，以及聽取業績電話會議。大多數分析師每三個月做一次這樣的評級，因此每家公司每年應該獲得4次評級。MorphoSys的最新評級是在2023年11月21日公佈的，因此您應該預計下一個評級將在2024年11月21日左右公佈。
Is the Analyst Rating MorphoSys (MOR) correct?
分析師的評級 MorphoSys (MOR) 是否正確？
While ratings are subjective and will change, the latest MorphoSys (MOR) rating was a reiterated with a price target of $0.00 to $17.00. The current price MorphoSys (MOR) is trading at is $4.54, which is within the analyst's predicted range.
儘管評級是主觀的，並且會發生變化，但最新的MorphoSys（MOR）評級得到了重申，目標股價爲0.00美元至17.00美元。MorphoSys（MOR）目前的交易價格爲4.54美元，在分析師的預測區間內。
譯文內容由第三人軟體翻譯。